Differential Discussions

Guest Series: Have We Cured Hemophilia? Part 1

28 min · 4 de jun de 2025
Portada del episodio Guest Series: Have We Cured Hemophilia? Part 1

Descripción

Malissa & Dave are joined by George Fritsma. George Fritsma manages www.fritsmafactor.com [http://www.fritsmafactor.com], The Fritsma Factor, Your Interactive Hemostasis Resource for Precision BioLogic Inc., Dartmouth, NS; and “Coag Conversations” for BioMedica Diagnostics, Inc., Windsor, NS. If you want to learn more about George, please view this author interview: https://aob.amegroups.org/post/view/readers-rsquo-choice-author-interview-with-dr-george-a-fritsma [https://aob.amegroups.org/post/view/readers-rsquo-choice-author-interview-with-dr-george-a-fritsma]

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Differential Discussions!

Empezar

2 meses por 1 €

Después 4,99 € / mes · Cancela cuando quieras.

  • Podcasts exclusivos
  • 20 horas de audiolibros / mes
  • Podcast gratuitos

Todos los episodios

32 episodios

Portada del episodio Guest Series: The Use of Chromogenic Factor X Assays for Monitoring Patients on Warfarin Therapy

Guest Series: The Use of Chromogenic Factor X Assays for Monitoring Patients on Warfarin Therapy

Malissa & Dave are joined by David McGlasson to talk about chromogenic factor X assays and their use monitoring patients on warfarin. David McGlasson was a GS-13 staff researcher at the 59th Clinical Research Division at Lackland JBSA in Sant Antonio, TX until retirement. He holds degrees from the University of Incarnate Word and San Antonio College in San Antonio, TX and certification from the Gradwohl Schoolf of Laboratory Technique in Medical Technology. To read more about David, you can visit the Diapharma website https://diapharma.com/clot-club-david-mcglasson/ [https://diapharma.com/clot-club-david-mcglasson/] Here is the link to the article about chromogenic factor X assays: https://diapharma.com/news-and-events/chromogenic-factor-x-assays-vs-the-pt-inr-to-monitor-subjects-on-coumadin-therapy-when-an-individual-approach-is-necessary/ [https://diapharma.com/news-and-events/chromogenic-factor-x-assays-vs-the-pt-inr-to-monitor-subjects-on-coumadin-therapy-when-an-individual-approach-is-necessary/]

1 de abr de 202544 min